Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment

References

• Ono H, Yao K, Fujishiro M, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48(2):225–229.
   PubMed Web of Science ®Google Scholar
• Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hirasawa T, Gotoda T, Miyata S, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12(3):148–152.
   PubMed Web of Science ®Google Scholar
• Probst A, Pommer B, Golger D, et al. Endoscopic submucosal dissection in gastric neoplasia – experience from a European center. Endoscopy. 2010;42(12):1037–1044.
   PubMed Web of Science ®Google Scholar
• Gotoda T, Jung HY. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer. Dig Endosc. 2013;25(Suppl. 1):55–63.
   PubMedGoogle Scholar
• Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205.
   PubMed Web of Science ®Google Scholar
• Abe N, Gotoda T, Hirasawa T, et al. Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older. Gastric Cancer. 2012;15(1):70–75.
   PubMed Web of Science ®Google Scholar
• Abe S, Oda I, Suzuki H, et al. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy. 2015;47:1113–1118.
   PubMedGoogle Scholar
• Mori G, Nakajima T, Asada K, et al. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan. Gastric Cancer. 2016;19(3):911–918.
   PubMed Web of Science ®Google Scholar
• Kim SG, Kim SG, Park CM, et al. Long-term clinical outcomes of endoscopic submucosal dissection in patients with early gastric cancer: a prospective multicenter cohort study. Gut Liver. 2018;15:402–410.
   Google Scholar
• Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–1095.
   PubMed Web of Science ®Google Scholar
• Park WY, Lee SJ, Kim YK, et al. Occurrence of metachronous or synchronous lesions after endoscopic treatment of gastric epithelia dysplasia – impact of histologic features of background mucosa. Pathol Res Pract. 2018;214(1):95–99.
   PubMed Web of Science ®Google Scholar
• Ami R, Hatta W, Iijima K, et al. Factors associated with metachronous gastric cancer development after endoscopic submucosal dissection for early gastric cancer. J Clin Gastroenterol. 2017;2017:494–499.
   Google Scholar
• Seo JH, Park JC, Kim YJ, et al. Undifferentiated histology after endoscopic resection may predict synchronous and metachronous occurrence of early gastric cancer. Digestion. 2010;81(1):35–42.
   PubMed Web of Science ®Google Scholar
• Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372(9636):392–397.
   PubMed Web of Science ®Google Scholar
• Han SJ, Kim SG, Lim JH, et al. Long-term effects of Helicobacter pylori eradication on metachronous gastric cancer development. Gut Liver. 2018;12(2):133–141.
   PubMed Web of Science ®Google Scholar
• Cheung KS, Chan EW, Wong AYS, et al. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 2018;67(1):28–35.
   PubMed Web of Science ®Google Scholar
• Hatta W, Gotoda T, Oyama T, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: “eCura system”. Am J Gastroenterol. 2017;112(6):874–881.
   PubMed Web of Science ®Google Scholar
• Kimura K, Satoh K, Ido K, et al. Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl. 1996;214:17–20.
   PubMedGoogle Scholar
• Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789.
   PubMed Web of Science ®Google Scholar
• Maehata Y, Nakamura S, Fujisawa K, et al. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 2012;75(1):39–46.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334(16):1018–1022.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90(9):1401–1406.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Fossmark R. Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man. Gut. 2018;67(1):199–200.
   PubMed Web of Science ®Google Scholar
• Fossmark R, Sagatun L, Nordrum IS, et al. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival. APMIS. 2015;123(6):509–514.
   PubMed Web of Science ®Google Scholar
• Takaoka S, Hirotsu Y, Ohyama H, et al. Molecular subtype switching in early-stage gastric cancers with multiple occurrences. J Gastroenterol. 2019;54(8):674–686.
   PubMed Web of Science ®Google Scholar